MAY 24, 2018 02:21 AM PDT
Brain and Gut Link in Multiple Sclerosis
WRITTEN BY: Nouran Amin
3 25 1068

Scientists have discovered a new molecular pathway connecting brain and gut that if learned how to control, may be able to treat Multiple Sclerosis and other neurological disorders.

 

"We essentially discovered a remote control by which the gut flora can control what is going on at a distant site in the body, in this case the central nervous system," says lead researcher and neurologist Francisco Quintana from Harvard University.

This remote control is based around two categories of cells in our central nervous system functions: microglia and astrocytes.

Microglia are immune cells that hunt the the central nervous system seeking old and damaged cells that can contribute to inflammation. Astrocytes are a brain support cell that prevent inflammation. Ironically, astrocytes also possess inflammation promoting properties.

Human brain tissue, astrocytes in blue (Jorge Ivan Alvarez/University of Pennsylvania)

In the study, the researchers examined dietary changes on mice with a mouse form of multiple sclerosis, particularly observing effects. What was found was the consumed levels of tryptophan allowed the production of two proteins TGF-alpha and VEGF-b

TGF alpha is good, because it binds to receptors on the astrocytes, inhibiting inflammation. The other protein, VEGF-B, also binds to astrocytes, however, this type of binding produces inflammation.

"One of the biggest unanswered questions we had is: what mediates the crosstalk between microglia and astrocytes?" Quintana explains. "VEGF-B seems to boost pathogenic or pro-inflammatory responses of astrocytes, while TGF alpha does exactly the opposite."

The investigators acknowledge that still plenty of work needs to be completed in this area and the tryptophan discovery is just the start of the journey.

In the future, research will examine the presence of metabolites and if it affects the astrocyte receptors, as well as the examination of molecules released by gut bacteria in more detail. Ultimately, researchers hope to be able to control this process therapeutically. Using targeted chemicals to activate this anti-inflammation channel, inside our metabolism. “We are a long way away from being able to make recommendations about diet in MS. It's premature to recommend any dietary changes or interventions," explains Bruce Beno, and executive VP of research at the National MS Society.

"We hope that within the next few years, drugs can be found for trials and tested in patients."

Source: Nature

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
FEB 09, 2018
Immunology
FEB 09, 2018
How the Immune System Determines Friend From Foe
It is the immune system’s duty to distinguish helpful bacteria from harmful bacteria. Thanks to millions of years of humans and bacteria evolving in
APR 17, 2018
Immunology
APR 17, 2018
New Experimental Model for ALS and MS Immunotherapies
A new mouse model allows researchers to study the impact of immune cell function in the brain on diseases like amyotrophic lateral sclerosis (ALS) and mult
MAY 16, 2018
Immunology
MAY 16, 2018
Antibodies Neutralize Two Different Hemorrhagic Fever Viruses
Scientists have found evidence for potential antibody-based therapeutics to treat more than one hemorrhagic fever virus at once. From Harvard Medical Schoo
MAY 24, 2018
Immunology
MAY 24, 2018
Isolating a Neurological Protein May Protect Against Inflammatory Disorders
Investigators from Osaka University have isolated a neurological protein involved in the activation of immune cells that normally protect against inflammat
JUN 06, 2018
Immunology
JUN 06, 2018
Why are women more prone to autoimmunity than men?
For a long time scientists have been trying to understand why females are more likely than males to develop autoimmune diseases. From the University of Got
JUN 13, 2018
Health & Medicine
JUN 13, 2018
Insurance Denials Prevent Patients From Getting Hep C Medication
Some ads are running on television and in major magazines about drugs for hepatitis C, known as Hep C or HCV. Available in the United States since 2014, th
Loading Comments...